Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > Bob Farrell…phase one

<< Previous

Bullboard Posts

Next >>

Comment by PTBaileyon Jan 29, 2022 10:52am

186 Views

Post# 34374358

RE:Bob Farrell…phase one

Couple of things, if Amazigh is close in his prediction of SP and if we are still on track to complete phase one by end of 1st quarter it has to start any day now.

As well phase 1 will now be 5 cohorts rather than the 4 cohorts CMAX required. If every cohort gives a bump in SP it provides one more opportunity for a bump. Every time we start a new cohort we know the previous one was a success because they would not be prceeding to the next if it wasn't.

Every morning I wake I expect to see a phase 1 NR, because the timeline to completion is getting tighter.

The last few weeks of delay in the process is due to reems of techenical material the Ethics Committee is having to process. There was a sample of this info. posted in the FB group, seems very complex.

I help administer that site so let me know if you would like to join.